Alembic Pharmaceuticals added 2.50% to Rs 1277.65 after the company announced the successful completion of the United States Food and Drug Administration (US FDA) inspection for its oncology formulation facility located at Panelav, Gujarat.
Subscribe To Our Free Newsletter |